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Summary 
A novel murine plasma membrane protein has been 
identified in subpopulations of macrophages. It has 
an intracellular N-terminal domain, a transmembrane 
domain, and an extracellular region with a short 
spacer, an 89 Gly-Xaa-Yaa repeat-containing collage- 
nous domain, and a C-terminal cysteine-rich domain. 
In situ hybridization and immunohistochemical stain- 
ing have localized the protein to a subset of macro- 
phages in the marginal zone of the spleen and the med- 
ullary cord of lymph nodes. No expression was 
observed in macrophages of liver or lung. Transfected 
COS cells synthesized a native trimeric plasma mem- 
brane protein that bound labeled bacteria and acet- 
ylated LDL, but not yeast or Ficoll. The results suggest 
that the novel protein is a macrophage-specific mem- 
brane receptor with a role in host defense, as it shows 
postnatal expression in macrophages, which are con- 
sidered responsible for the binding of bacterial anti- 
gens and phagocytosis. 
Introduction 
Macrophages form an important part of the host defense 
system in normal and pathological processes. These cells 
are derived from a pool of monocytes that have migrated 
from blood into peripheral tissues such as those of the 
liver, spleen, lung, lymph nodes, peritoneum, skin, brain, 
and bone, where they differentiate into macrophages (Van 
Furth, 1982). 
The major characteristic of macrophages is their ability 
to recognize, internalize, and destroy a variety of foreign 
and endogenous ubstances and pathogens, such as bac- 
teria, parasites, and viruses. The exact recognition mech- 
anism for nonself pathogens is unknown, but it has been 
proposed that receptors with broad binding specificity are 
used to discriminate between self and nonself (Gordon et 
al., 1988; Krieger and Hertz, 1994). Macrophages are also 
thought to play a role in the immune response by pre- 
senting foreign antigens to lymphocytes (Unanue and Al- 
len, 1987). 
Macrophage scavenger receptors with broad ligand 
specificity have been suggested to play a role in the bind- 
ing of foreign antigens, in addition to their apparently im- 
portant role in atherogenesis (for review, see Krieger and 
Hertz, 1994). Scavenger receptors types I and II are tri- 
meric membrane proteins with a small N-terminal intracel- 
lular domain, a transmembrane domain, and an extracellu- 
lar region containing a short spacer domain, an a-helical 
coiled-coil domain, and a triple-helical collagenous do- 
main (Kodama et al., 1990; Rohrer et al., 1990). The type 
I receptor contains an additional C-terminal cysteine-rich 
domain, These receptors, which are present in macro- 
phages in diverse tissues, including liver and lung, have 
been shown to bind a variety of ligands, such as chemically 
modified lipoproteins and albumin, polyribonucleotides, 
polysaccharides, phospholipids, and asbestos (Krieger 
and Hertz, 1994). Furthermore, the scavenger receptors 
are thought o play a key role in atherogenesis by mediat- 
ing uptake of modified low density lipoprotein (LDL) in arte- 
rial walls, and in host defense by binding bacterial endotox- 
ins, bacteria, and protozoa (Krieger and Hertz, 1994). 
Several collagenous proteins without structural functions 
belong to the host defense system, such as complement 
factor Clq, conglutinin, mannose-binding proteins, and 
pulmonary surfactant-associated proteins. 
In the present study, we have cloned and characterized 
a novel macrophage receptor with a coilagenous tructure 
(referred to as MARCO) that is expressed postnatally in 
a subset of macrophages in mouse spleen and lymph 
nodes, but not in the liver or lung. This receptor was shown 
to bind to bacteria and acetylated LDL, but not to yeast. 
Results 
cDNA Clones and Predicted Primary Structure 
Screening of a mouse macrophage cDNA library with a 
human type Xlll collagen cDNA probe yielded several 
clones spanning 1.8 kb encoding a protein that has not, to 
our knowledge, been described previously. This sequence 
contained an apparent 159 bp 5'-end untranslated region 
and a 1554 bp open reading frame, followed by a />156 
bp 3'-end untranslated region containing aTGA translation 
stop codon, a putative AATAAA polyadenylation signal, 
and a poly(A) tail. The sequence surrounding the putative 
initiator methionine codon ATG does not agree completely 
with the Kozak consensus sequence, but it can be desig- 
nated as a strong translation initiation site when positions 
-3 and +4 are being considered (Kozak, 1989). 
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Figure 1. Nucleotide-Derived Amino Acid Sequence of the Murine 
MARCO Subunit Chain 
The cDNA-deduced amino acid sequence is shown with the single- 
letter code. The tentative transmembrane domain II is indicated by an 
underline, and cysteine residues and the two potential glycosylation 
sites are circled. The collagenous domain iV is boxed. 
The cDNA-d erived 518 amino acid sequence was shown 
to be unique (Figure 1) for a polypeptide of 52,738 Da. 
The open reading frame starts with a hydrophilic domain 
I (residues 1-49) containing one cysteine, and thus, the 
protein does not contain a hydrophobic signal peptide. 
The hydrophobic domain II (residues 50-74) is followed 
by a hydrophilic domain III (residues 75-149) containing 
two cysteine residues and two putative N-glycosylation 
sites (Figure 1). Domain IV (residues 150-419) has a typi- 
cal collagenous sequence characterized by 89 Gly-Xaa-  
Yaa triplets interrupted at one location (residues 174-176) 
by Ala-Glu-Lys.  The C-terminal domain V (residues 420- 
518) has six cysteines. This domain showed 48.9% se- 
quence identity with the C-terminal domain of scavenger 
receptor type I. The sequences of domains I, II, and III 
showed no significant homology with the scavenger recep- 
tor or other known proteins. The novel macrophage recep- 
tor with collagenous structure described here is referred 
to as MARCO. 
Expression of MARCO 
By Northern blot analyses, MARCO was shown to be 
strongly expressed in spleen and peritoneal macrophages 
of adult mice, but not in other tissues, and also in a cultured 
macrophage cell line IC-21 (ATCC TIB 186) (data not 
shown). 
By use of in situ hybridization, no signals above back- 
ground were observed in 14- to 17-day-old embryonic tis- 
sues (data not shown), but strong signals were seen with 
the MARCO antisense probe in a highly region-specific 
manner, in both spleen and lymph nodes of 2-month-old 
mice (Figures 2A, 2B, 2G, and 2H). In contrast, all other 
tissues examined, including lung and liver, which are rich 
in macrophages, did not show signals above background 
(data not shown). In the spleen, the signals were present 
in macrophage-like cells in the marginal zone at the inter- 
face of the white and red pulps (Figures 2A and 2B). In 
Figure 2. In Situ Hybridization Analyses of MARCO Expression and 
Comparison of Immunolocalization of MARCO and Macrophage ER- 
TR9 and MOMA-1 Antigens in Mouse Spleen and Lymph Node 
Hybridization with the MARCO antisense probe (A and S) showed 
strong signals in cells located in a circle-like array in the marginal zone 
(mz) between the white (w) and red (r) pulps. Immunostaining with an 
antibody against he intracellular domain I of MARCO (C) and with the 
ER-TR9 antibody specific for marginal zone macrophages (D) showed 
codistribution of antigens. Double immunostaining with the MARCO 
(blue) and ER-TR9 antibodies (red) showed some marginal zone mac- 
rophages positive for MARCO, but negative for ER-TR9 (E). Double 
staining with MARCO (blue) and MOMA-1 (red) antibodies shows, re- 
spectively, staining of marginal zone macrophages and metallophilic 
macrophages lining the marginal sinus (F). Hybridization with the 
MARCO antisense probe (G and H, dark and light fields, respectively) 
showed strong signals in cells located in the medullary cord region 
of the lymph node. Abbreviations: c, capsule; mc, medullary cord; pc, 
paracortex. Scale bars in (A), 800 pro; in (B)~ 80 p.m; in (C)-(F), 35 
p.m; in (G) and (H), 400 p.m. 
lymph nodes, strong signals were seen in macrophages 
of the medullary region (Figures 2G and 2H). A sense 
probe did not reveal positive signals in any of the tissues 
studied (data not shown). 
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Figure 3. Field Emission Scanning Immunoelectron Microscopy Lo+ 
calization of MARCO in Cultured Macrop~ages (IC-21) and Binding 
of MARCO Antibodies to Spleen Marginal Zone Macrophages In Vivo 
(A) Transformed IC-21 macrophages were ncubated with an antibody 
against domain V of MARCO. Intense gold label can be seen on the 
cell surface proper and on pseudopodia (magnification, 32,500 x). No 
label was observed with antibodies against domain I(data not shown). 
(B) For studies in vivo, rabbit antiserum to the extracellutar domain V 
of MARCO was injected intravenously into a mouse, after which tissue 
was removed and processed for staining using an FITC-labeled anti- 
rabbit IgG. The label was confined to marginal zone (mz) macrophages 
located between the red (r) and white (w) pulps. Antibodies against 
domain I did not bind cells (data not shown). 
Scale bars in (A), 100 nm; in (B), 10 pro. 
Immunohistochemical Localization of MARCO 
to Macrophages 
The MARCO protein was immunolocalized by using anti- 
bodies raised against the putative extracellular and in- 
tracellular domains I and V, respectively. Analysis of 
2-month-old mouse spleen tissues revealed specific stain- 
ing in macrophages located in the marginal zone with both 
antibodies (Figure 2C). No specific staining was observed 
in liver, which is rich in scavenge~" receptor-containing 
macrophages. The immunohistochemical analysis showed 
codistribution of MARCO and the marginal zone macro- 
phage marker ER-TR9 (Dijkstra et al., 1985) in macro- 
phages of spleen (Figures 2C, 2D, and 2E) and in lymph 
nodes (data not shown). Neither MARCO nor ER-TR9 anti- 
gens were present in macrophages lining the marginal 
sinus, which normally express the sialoadhesin receptor 
recognized by the MOMA-1 antibody(Figure 2F; Kraal and 
Janse, 1986; Kraal, 1992). 
Immunolocalization and Orientation of MARCO 
on the Macrophage Cell Surface 
Cultured IC-21-transformed macrophages were processed 
for field emission scanning electron microscopy of the cell 
surface and reacted with antisera against domains I and 
V followed by incubation with a gold-labeled second anti- 
body. The antibody against the C-terminal domain V 
readily bound to the cell surface (Figure 3A), while the 
antibody against the N-terminal domain I did not (data not 
shown). The antibodies evenly decorated the cell surface 
and protruding pseudopodia. 
The orientation of MARCO in the plasma membrane was 
further investigated by injecting antisera against domains 
I or V intravenously into mouse, after which the tissues 
were analyzed for staining by using a fluorescein isothiocy- 
anate (FITC)-conjugated second antibody. All tissues 
studied were negative, except for the spleen, which exhib- 
ited staining of marginal zone macrophages with antise- 
rum against domain V (Figure 3B). However, no staining 
was observed with domain I antibodies (data not shown). 
Together, these results demonstrated that domains I and 
V are intracellular and extracellular, respectively. 
MARCO Is a Disulfide-Linked Trimer 
The presence of several cysteine residues and a 270- 
residue Gly-Xaa-Yaa repeat-containing sequence indi- 
cated that MARCO is a disulfide-linked trimer with a colla- 
gen triple helix. To analyze this, protein was extracted from 
mouse spleen or kidney tissues, immunoprecipitated, and 
separated by SDS-polyacrylamide gel electrophoresis 
(PAGE) followed by immunoblotting. When protein from 
spleen was analyzed on SDS-PAGE without reduction, a 
major band of - 210,000 Da and a second slightly smaller 
band were seen with both antibodies (Figure 4A, lanes 1 
and 2). A 160,000 Da band representing immunoglobulin 
G (IgG) was also detected. After reduction, one diffuse 
major band of -80,000 Da and one weaker, slightly 
smaller band were observed (Figure 4A, lane 5), in addition 
to a strong 50,000 Da IgG band. No specific protein was 
immunoprecipitated from the kidney extract with the 
MARCO antibodies (see Figure 4A, lanes 3, 4, and 6). 
These results demonstrated that MARCO is a disulfide- 
linked trimer. The smaller bands recognized by both anti- 
bodies might represent forms with different posttransla- 
tional modifications. 
Metabolic Labeling of Transfected COS Cells 
COS cells, which do not express MARCO, were trans- 
fected with the cDNA in the presence or absence of tuni- 
camycin to study glycosylation of the protein, and also to 
determine whether native MARCO trimers can be formed 
with a single chain type. Incubation with tunicamycin, 
which inhibits N-glycosylation, revealed a MARCO chain 
of -50,000 Da, which agrees well with the calculated size 
(Figure 4B, lane 5). When the cells were pulse labeled for 
1 or 4 hr, the major band had a size of about 60,000 Da. 
Additionally immunoprecipitated bands of sizes up to 
80,000 Da were observed after reduction (Figure 4B, lane 
3). Following an 18 hr chase, the 60,000 Da bands had 
disappeared, but two bands of 70,000 Da and a doublet 
of about 80,000 Da remained (Figure 4B, lane 4). These 
results suggest that the microheterogeneity of the subunit 
MARCO chains is due to differences in glycosylation, but 
not proteolysis, as these proteins were detected with anti- 
bodies reacting with both ends of the polypeptide (data 
not shown). 
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Figure 4• Immuneprecipitation and Immune- 
blot Analyses of MARCO from Mouse Tissues 
and Transfected COS Cells 
(A) Protein from spleen and kidney was ex- 
tracted, immunoprecipitated with antisera 
against recombinant domains I (N) or V (C) of 
MARCO, electrophoresed on a 50/0 gel without 
reduction, and immunoblotted. The antisera 
precipitated a 210,000 Da protein from spleen 
(lanes 1 and 2), while no proteins were precipi- 
tated from the kidney (lanes 3 and 4) extract• 
The broad band of about 160,000 Da seen in 
both spleen and kidney samples is immune- 
globulin. When the same samples were electro- 
phoresed on 80/0 gels after reduction, a major 
band of about 80,000 Da was present in the 
spleen sample (lane 5), but not in that of kidney (lane 6). A broad -50,000 Da band representing IgG chains was seen in both samples. 
(B) Protein extracts of [35S]methionine-labeled COS cells transfected with the Marco cDNA (MARCO) or the same cDNA in the opposite orientation 
(control) were immunoprecipitated with MARCO antiserum, electrophoresed, and processed for autoradiography. After a 4 hr pulse, the immunopre- 
cipitate migrated as a 210,000 Da protein doublet under nonreducing conditions on 5% SDS-PAGE (lane 1). After reduction, the major band had 
a size of about 60,000 Da, with additional bands corresponding to differentially glycosylated forms of up to 80,000 Da also present (lane 3). After 
an 18 hr chase, two bands of 70,000 Da and a doublet of about 80,000 Da remained (lane 4). Incubation with tunieamycin revealed a band of 
50,000 Da (lane 5). No specific protein was precipitated from control samples (lanes 2 and 6). 
Pulse-labeled immunoprecipitated MARCO extracted 
from the transfected cells was compared with that immu- 
noprecipitated from a spleen tissue extract. The sizes of 
trimeric MARCO from the COS cells (Figure 4B, lane 1) 
corresponded to those from spleen (Figure 4A, lanes 1 
and 2). Thus, the transfected cells were able to synthesize 
single MARCO chains and assemble them into disulfide- 
bonded homotrimers. 
Binding Propert ies  of MARCO 
Since marginal zone macrophages in the spleen are 
thought to recognize and phagocytose blood pathogens 
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such as bacteria and yeast, the potential binding proper- 
ties of MARCO were studied in transfected COS cells, and 
in IC-21 macrophages (positive control), in the presence 
of fluorescein-labeled bioprobes. Transfected COS cells 
specifically bound Escherichia coli and Staphylococcus 
aureus bacteria (Figures 5A and 5B), while labeled Sac- 
charomyces cerevisiae (Zymosan A) did not bind to the 
cells (Figure 5C). The binding of S. aureus could be inhib- 
ited efficiently by antiserum (data not shown) and IgG (Fig- 
ure 5G) raised against domain V. Binding of E. coli could 
also be inhibited by these antibodies (data not shown)• 
Transfected COS cells did not bind FITC-labeled Fi- 
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Figure 5. Binding Studies of MARCO-Expressing COS Cells with Fluorescein-Labeled E. coli, S. aureus, and Zymosan A (S. cerevisiae) 
Transfected COB cells or IC-21 macrophages were incubated with FITC-labeled S. aureus (A and D), E. coli (B and E), or Zymosam A (C and F). 
The MARCO-expressing COS cells were visualized by immunostaining with MARCO antibodies and a rhodamine-labeled secondary antibody. 
The IC-21 cells were stained with ethidium bromide. Only MARCO-positive COS cells showed specific binding of E. coli and S. aureus (A and B), 
while these cells did not bind Zymosan A (S. cerevisiae) (C). In contrast, the IC-21 macrophages bound all three probes (D, E, and F). Effects of 
preimmune and anti-MARCO IgG on the binding of S. aureus are shown in (G). The binding is depicted as a percentage, the binding in the absence 
of IgG being set as 100%. 
MARCO, a Macrophage-Specific Bacteria-Binding Receptor 
607 ~ 
CCC 
v ! J  
99 aa ':" C C C 
<i~ 
"hinge" ~ IE'~:...i:: ':" 16 I _ _  
,,, g 
I y....~ d'.--, I 
N NN N N N 
MARCO Scavenger 
receptor I
Figure 6. Comparison of the Predicted Tertiary Structures of MARCO 
and Scavenger Receptor Type I 
Both molecules have intracellular nd transmembrane domains I and 
II of similar sizes. The putative spacer domain I11 is about 2-fold longer 
in MARCO than in the scavenger receptor. The collagenous extracellu- 
lar stem domain IV of MARCO, which has a tentative hinge formed 
by a single noncollagenous Ala-Glu-Lys triplet, is slightly longer than 
the combined size of the coiled-coil domain IV and collagenous domain 
V of the scavenger eceptor. The C-terminal cysteine-rich domains 
have similar sizes. (For references, see Freeman et al. [1990].) The 
domains are indicated by Roman numbers, and the amino acid (aa) 
residue sizes of the subunit chains are indicated below. 
coil, a neutral polysaccharide normally taken up by 
marginal zone macrophages, while the IC-21 macro- 
phage cells readily bound this compound (data not shown). 
We further showed that MARCO-expressing COS cells 
bound 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocya- 
nine perchlorate(Dil)-acetylated LDL (data not shown). 
Discussion 
The present study provides a description of MARCO, a 
macrophage receptor with collagenous structure ex- 
pressed in specific macrophages in spleen and lymph 
nodes. This receptor was shown to bind both gram-positive 
and gram-negative bacteria and acetylated LDL, but not 
yeast. The structure of MARCO shows some resemblance 
to scavenger receptor type I (Kodama et al., 1990), but it 
is clearly a distinct gene product with different binding 
properties. 
MARCO Is a Membrane-Bound Trimer 
The cDNA-derived amino acid sequence and protein stud- 
ies carried out showed that MARCO is a disulfide-bonded 
trimer with a partial collagenous structure. The tuni- 
camycin labeling studies demonstrated that the 210,000 
Da protein observed by SDS-PAGE was due to glycosyla- 
tion of the three -52,000 Da subunits. The Ala-Glu-Lys 
interruption in the collagenous sequence of the polypep- 
tide chain indicates that the triple helix of MARCO has 
a kink or hinge similar to that present in collagens with 
interrupted triple helices. At present, it is not known 
whether the MARCO molecules in vivo are homo- or heter- 
otrimers, but our experiments demonstrated that homotri- 
mers can be formed in transfected COS cells. 
The primarystructure ofMARCO already suggested that 
it is not a secreted protein, as it does not contain a typical 
signal peptide sequence. The hydrophobic sequence of 
domain II further indicated that MARCO is a membrane 
protein, and this was confirmed in various immunological 
studies that clearly localized the protein to the plasma 
membrane. 
MARCO Resembles Scavenger Receptor Type I 
The primary structure of the MARCO subunit chain is simi- 
lar to that of the scavenger receptor, and furthermore, the 
predicted tertiary structure (Figure 6) and the polarity of 
amino acids next to the hydrophobic domain II strongly 
indicate that MARCO is an integral trimeric membrane 
molecule, each chain having a single membrane-span- 
ning domain as in the scavenger receptor (Kodama et al., 
1990). The present study verified the orientation of 
MARCO, showing that domain V is extracellular and do- 
main I intracellular. The 75 residue extracellular domain III 
of MARCO probably acts as a spacer between the plasma 
membrane and domain IV. The latter differs substantially 
from the coiled-coil region formed by domains IV and V 
of the scavenger receptor in that it forms a triple-helical 
collagenous domain interrupted at a single site by an Ala- 
Glu-Lys sequence, while the scavenger receptor has first 
a long noncollagenous a-helical coiled coil followed only 
by a short 24 Gly-Xaa-Yaa repeat containing domain V 
(Kodama et al., 1990). The C-terminal end domains V and 
VI of MARCO and scavenger receptor type I, respectively, 
show a 48.9% similarity (Figure 7), each containing six 
cysteine residues with similar spacing. This scavenger re- 
ceptor cysteine-rich motif (SRCR domain) has been found 
in a number of other proteins. All of the known mammalian 
M_~q.CO 423 ~IMG..Gr~GRAEVYYNNEWGT~DD~fD~ArEV~E~MLGYSRGI~-L. 470 Figure 7. Comparison of the Amino Acid Se- 
l l : : /  I: II I:: : I l J l l l l l l  II i l l  I] I I[ l: quenceoftheCysteine-RichExtracellularDo- 
Murine SR 352 VRLVGGSGAHEGRVEIFHQGQWGT CI~DDRWDIRAGQVV~SLGYQEVLAVH 401 
mains V and VI of Mudne MARCO and Scaven- 
ger Receptor Type I, Respectively 
MARCO 471 . .SSYGGGSGNIWLDN~/k~GTENSLWE~KIqSWGNH~VHNEDAGV~. 518 
: :1 I : l  I l l  ! I[I I I I :  :111 I I r Iii I l i l l e  ]11: The two domain sequences have been aligned 
Murine SR 402 KRAHFGQGTGPIWLNE~AV~FGRESSIEh~INQWGVLS~]SHSEDAGVT~S 453 for maximal  match. Solid bars between the se- 
quences indicate conserved amino acids, and 
double colons depict conservative substitutions. The six conserved cysteine residues are boxed. The residues of MARCO are numbered according 
to Figure 1, and those of scavenger receptor according to Freeman et al. (1990). 
Cell 
608 
SRCR domain-containing proteins are expressed on the 
surfaces of cells associated with the immune system and 
host defense functions (T cells, B cells, and macrophages) 
or are secreted and known or suspected of being involved 
in host defense (Resnick et al., 1994; Freeman et al., 
1990). 
Cell Specificity and Bacteria Binding Properties 
of MARCO Indicate a Role in Host Defense 
The binding of MARCO to bacteria and the expression of 
this protein in specific macrophage subpopulations indi- 
cate that it plays a role in immunological reactions, and 
they emphasize the heterogeneity within macrophage 
populations and the compartmentalization of the lymphoid 
system. The marginal zone macrophages of the spleen 
where MARCO is highly expressed form a very special 
population in many respects. These large macrophages 
are strategically positioned in the anatomical compart- 
ment of the spleen where the bloodstream leaves the small 
arterioles and passes into the so-called open venous sys- 
tem (Kraal, 1992). Here, the phagocytosing system first 
contacts blood-borne pathogens, and the highly phago- 
cytic marginal zone macrophages, especially, can bind 
and take up material. The antibody inhibition studies indi- 
cated that domain V contains the ligand-binding site, but 
since the antigen contained a small part of domain IV, it 
cannot be excluded that domain IV has ligand binding 
properties. Also, steric hindrance of the antibodies cannot 
be excluded. 
Despite structural similarities with the scavenger recep- 
tor type I, MARCO probably has different functions, as it 
is present in different ypes of macrophages. For example, 
MARCO was not found in liver or lung tissues. However, 
MARCO binds acetylated LDL and bacteria, as do scaven- 
ger receptors, but it differs by not binding yeast. The re- 
stricted expression of MARCO in macrophages capable 
of binding and possibly taking up acetylated LDL points 
to a significant role in the clearance of serum components. 
Taken together, the binding properties and restricted 
expression of MARCO in subpopulations of macrophages 
that are involved in the uptake of bacterial antigenic poly- 
saccharides indicate that MARCO plays an important role 
in the host defense system and homeostasis of the body. 
Experimental Procedures 
Isolation and Characterization of cDNA Clones 
A mouse macrophage cDNA library in ~.gt11 (CIontech ML1005) was 
screened with a human type Xill collagen cDNA (E-26) probe (Pihlaja- 
niemi and Tamminen, 1990). The clones were isolated, subcloned into 
pUC18/19 or M1318/19 vectors, and sequenced in accordance with 
standard procedures. 
RNA Analysis and In Situ Hybridization 
Poly(A) RNA was isolated from tissues (liver, kidney, spleen, lung, 
heart, muscle, brain, and thymus) of 2-month-old mice and transferred 
to nitrocellulose by standard methods. 
In situ hybridization was carried out (Wilkinson and Green, 1990) 
on whole 14- and 17-day-old mouse embryos and on lung, liver, spleen, 
lymph node, kidney, and heart tissues of 9-day-old pups, as well as 
on bone marrow, intestine, lung, liver, spleen, lymph node, kidney, 
and thymus tissues of adult mice. For the preparation of RNA probes, 
DNA fragments (nucleotides 65-398 and 1310-1672) were amplified 
by polymerase chain reaction (PCR) using the Marco cDNA clone as 
template. PCR primers contained restriction sites for subcloning into 
pSP64 and pSP65 plasmid vectors (Promega). 
Preparation of Antibodies 
Monoclonal antibodies, ER-TR9 and MOMA-1, against macrophage 
antigens have previously been described (Dijkstra et al., 1985; Kraal 
and Janse, 1986). For the production of polyclonal antibodies, domains 
of the MARCO polypeptide were expressed as glutathione S-trans- 
ferase (GST) fusion proteins in the pGEX-IZT vector (Pharmacia) in 
E. coll. DNA fragments encoding domain I (residues 1-50) or the 
end of domain IV plus domain V (residues 369-518) were generated 
by PCR. All sequences were confirmed by DNA sequencing. Fusion 
proteins produced in bacteria were purified using glutathione-Sepha- 
rose 4B (Pharmacia). Antisera were raised in rabbits by using standard 
procedure, and IgG was first purified by protein A-Sepharose (Phar- 
macia) and then by negative immunoabsorption from unspecific anti- 
bodies against GST and E. coli proteins. 
Immunolocalization 
For staining with monoclonal antibody against he macrophage marker 
ER-TR9 (Kraal, 1992), cryosections were incubated first with the anti- 
body and then with horseradish peroxidase (HRP)-conjugated rabbit 
anti-rat IgG second antibody (Dako, Denmark). HRP activity was dem- 
onstrated with aminoethyl carbazole (AEC) and H202, resulting in a 
red reaction product. For double staining, the sections were thereafter 
incubated with rabbit anti-MARCO IgG (100 pg/ml) against domain I 
or domain V and incubated with a swine anti-rabbit IgG-H RP conjugate 
(Dako, Denmark). HRP activity was now demonstrated using 4-chloro- 
1-naphtol and H202, resulting in a blue reaction product. For immuno- 
fluorescence microscopy, sections were incubated with anti-MARCO 
IgG (100 i~g/ml) and then with FITC-conjugated goat anti-rabbit IgG 
(Cappel). 
For field emission electron microscopy, cells were fixed with 4% 
and 8% paraformaldehyde for 10 rain each, followed by incubation 
with anti-MARCO IgG anti-rabbit IgG labeled with 30 nm gold particles 
(Amersham). The cells were postfixed with 2.5% glutaraldehyde, dehy- 
drated in alcohol, dried in Balzers CPD 030 critical point dryer, coated 
with a thin carbon layer, and examined in a Jeol JSM-6300 F electron 
microscope. 
Immunoprecipitation and SDS-PAGE 
Immunoprecipitation was carried out according to standard proce- 
dures (Sambrook et al., 1989). Prior to immunoprecipitation, the mem- 
branes were partially purified from mouse spleen and kidney according 
to the protocols of Schneider et al. (1980), and the membranes and 
cells were extracted into a triple detergent buffer (50 mM Tris-HCI 
[pH 8], 150 mM NaCI, 1% Nonidet P-40, 0.1% SDS, 0.5% sodiumdeox- 
ycholate, 100 p~g/ml phenylmethylsulfonyl fluoride (PMSF), 0.02% so- 
dium azide, 1 ~tg/ml aprotinin). The immunoprecipitation was then 
carried out essentially as described elsewhere (Sam brook et al., 1989). 
Reduced and nonreduced samples were separated by SDS-PAGE. 
Gels with radioactive protein samples were impregnated in EN ~ 
HANCE (Du Pont) prior to film exposure. Western blot analysis was 
carried out according to the protocols of Sambrook et al. (1989), using 
MARCO antisera dilutions of 1:50 to 1:100. The membranes were 
incubated with alkaline phosphatase-conjugated anti-rabbit IgG 
(Sigma) and developed with nitroblue tetrazolium-5-bromo-4-chloro-3- 
indolyl phosphate. 
Cell Culture, Transfections, and Metabolic Labeling 
Cell lines IC-21 and COS7 were from the American Type Culture Col- 
lection. IC-21 transformed mouse macrophages were grown in RPMI 
1640 medium, and COS7 cells in high glucose (4.5 g/I) Dulbecco's 
modified Eagle's medium (DMEM) (GIBCO) were supplemented with 
10% fetal calf serum (FCS), 2 mM L-glutamine, 100 IU/ml penicillin, 
and 75 i~g/ml ascorbate. For cell transfections, acDNA fragment con- 
taining the entire coding region of MARCO with the authentic transla- 
tion initiation sequence was generated by oligonucleotide-primed 
PCR. The product was cloned into the pSG5 expression vector (Stra- 
tagene; Green et al., 1988) through use of Bglll restriction sites engi- 
neered into the primers. Additionally, a construct made with a 5' PCR 
primer containing an additional consensus sequence, GCCGCCAC- 
MARCO, a Macrophage-Specific Bacteria-Binding Receptor 
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CATGG (Kozak, 1989), was made for more effective initiation of transla- 
tion. A construct containing the coding region in the opposite orienta- 
tion (3'-5') was used as a control. A day before transfection, COS7 
cells were plated at 7 x 1~ cells per 90 mm tissue culture dish and 
then transfected overnight by the calcium phosphate method using 
20 ~g of DNA isolated with CsCI gradient centrifugation. After 18 hr, 
the calcium phosphate precipitate was removed, and the cells were 
used for immunostaining or binding assays. 
For metabolic labeling, cells were incubated for 1 hr or 4 hr in methi- 
one-free DMEM containing 200 i~Ci/ml pS]methionine (Amersham; 
>1000 Ci/mmol) and 10% dialyzed FCS. The cells were then chased 
for 0, 3, 8, or 18 hr in medium suplementec' with unlabeled methionine. 
In N-glycosylation inhibition studies, 3 t~g/ml tunicamycin was included 
in the medium 3 hr before labeling and during the 4 hr labeling period. 
Ligand Binding Studies 
IC-21 macrophages (positive control) ana transfected COS cells cul- 
tured on coverslips were incubated with fluorescence-labeled ligand 
candidates (Molecular Probes, Incorporated); with FITC-labeled E. 
coil, S. aureus, or Zymosan A (S. cerevisiae) for 1 hr; with FITC-labeled 
Ficoll (50-100 p.g/ml) or with Dil-labeled Ac-LDL (5 i~g/ml) for 3-5 hr. 
Bacteria and cells were incubated in ratios of 50:1 to 100:1. In the 
Zymosan A binding studies, higher particle amounts and longer incu- 
bation times were also tested. Following incubation, the cells were 
immunostained with anti-MARCO IgG and FITC- or rhodamine-labeled 
secondary antibodies. As negative controls, COS cells transfected 
with a plasmid containing cDNA in the wrong orientation were used. 
Binding inhibition studies were carried out by adding normal rabbit 
IgG and MARCO anti-rabbit IgG (25-500 p.g/ml) or preimmune and 
anti-MARCO sera at dilutions of 1:10 to 1:100 prior to the addition of 
ligands. Bound bacteria were counted from 100 cells positive with 
anti-MARCO antibodies, each experiment being carried out in trip- 
licate. 
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